共 50 条
Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G
被引:14
|作者:
Gabriel, Martin
[1
]
Adomeh, Donatus I.
[2
]
Ehimuan, Jacqueline
[2
]
Oyakhilome, Jennifer
[2
]
Omomoh, Emmanuel O.
[2
]
Ighodalo, Yemisi
[2
]
Olokor, Thomas
[2
]
Bonney, Kofi
[3
]
Pahlmann, Meike
[1
]
Emmerich, Petra
[1
,4
]
Lelke, Michaels
[1
]
Brunotte, Linda
[1
,5
]
Olschlager, Stephan
[1
]
Thome-Bolduan, Corinna
[1
]
Becker-Ziaja, Beate
[1
]
Busch, Carole
[1
]
Odia, Ikponmwosa
[2
]
Ogbaini-Emovon, Ephraim
[2
]
Okokhere, Peter O.
[6
]
Okogbenin, Sylvanus A.
[7
]
Akpede, George O.
[8
]
Schmitz, Herbert
[1
]
Asogun, Danny A.
[2
]
Guenther, Stephan
[1
,9
]
机构:
[1] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany
[2] Irma Specialist Teaching Hosp, Inst Lassa Fever Res & Control, Irma, Edo State, Nigeria
[3] Univ Ghana, Noguchi Mem Inst Med Res, Dept Virol, Legon, Ghana
[4] Univ Rostock, Dept Trop Med & Infect Dis, Ctr Internal Med 2, Rostock, Germany
[5] Westfalische Wilhelms Univ Munster, Inst Mol Virol, Munster, Germany
[6] Irma Specialist Teaching Hosp, Dept Med, Irrua, Edo State, Nigeria
[7] Irma Specialist Teaching Hosp, Dept Obstet & Gynecol, Irrua, Edo State, Nigeria
[8] Irrua Specialist Teaching Hosp, Dept Pediat, Irrua, Edo State, Nigeria
[9] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Braunschweig, Germany
来源:
关键词:
REVERSE TRANSCRIPTION-PCR;
MARCH-APRIL;
1972;
MASTOMYS-NATALENSIS;
CLINICAL VIROLOGY;
HOSPITAL EPIDEMIC;
WEST-AFRICA;
FEVER VIRUS;
INFECTION;
DIAGNOSIS;
IMMUNOFLUORESCENCE;
D O I:
10.1371/journal.pntd.0006361
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
Background The classical method for detection of Lassa virus-specific antibodies is the immunofluorescence assay (IFA) using virus-infected cells as antigen. However, IFA requires laboratories of biosafety level 4 for assay production and an experienced investigator to interpret the fluorescence signals. Therefore, we aimed to establish and evaluate enzyme-linked immunosorbent assays (ELISA) using recombinant Lassa virus nucleoprotein (NP) as antigen. Methodology/Principal findings The IgM ELISA is based on capturing IgM antibodies using anti-IgM, and the IgG ELISA is based on capturing IgG antibody-antigen complexes using rheumatoid factor or Fc gamma receptor CD32a. Analytical and clinical evaluation was performed with 880 sera from Lassa fever endemic (Nigeria) and non-endemic (Ghana and Germany) areas. Using the IFA as reference method, we observed 91.5-94.3% analytical accuracy of the ELISAs in detecting Lassa virus-specific antibodies. Evaluation of the ELISAs for diagnosis of Lassa fever on admission to hospital in an endemic area revealed a clinical sensitivity for the stand-alone IgM ELISA of 31% (95% CI 25-37) and for combined IgM/ IgG detection of 26% (95% CI 21-32) compared to RT-PCR. The specificity of IgM and IgG ELISA was estimated at 96% 95% CI 93-98) and 100% (95% CI 99-100), respectively, in non-Lassa fever patients from non-endemic areas. In patients who seroconverted during follow-up, Lassa virus-specific IgM and IgG developed simultaneously rather than sequentially. Consistent with this finding, isolated IgM reactivity, i.e. IgM in the absence of IgG, had no diagnostic value. Conclusions/Significance The ELISAs are not equivalent to RT-PCR for early diagnosis of Lassa fever; however, they are of value in diagnosing patients at later stage. The IgG ELISA may be useful for epidemiological studies and clinical trials due its high specificity, and the higher throughput rate and easier operation compared to IFA.
引用
收藏
页数:17
相关论文